Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2011-04-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
NCT01592058
Postpartum Etonogestrel Implant for Adolescents
NCT01666912
Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
NCT03585504
Adolescent Postpartum Contraceptive Counseling Intervention
NCT01814930
Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism
NCT01527526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DMPA group
Subjects randomized to receive DepoProvera(DMPA) immediately post-partum.
DMPA immediately postpartum
DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.
Implanon group
Subjects randomized to receive Implanon immediately post-partum.
Implanon immediately postpartum
Implanon ® is a subdermal implant that contains 68mg of etonogestrel.
Control group
Subjects selecting their own method of contraception or no contraception.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DMPA immediately postpartum
DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.
Implanon immediately postpartum
Implanon ® is a subdermal implant that contains 68mg of etonogestrel.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-45 at enrollment (inclusive)
* Immediately postpartum of a live singleton infant, 37 weeks gestation, at HUP
* Desiring to delay another pregnancy for 6 months
* Willing and able to follow the study protocol
Exclusion Criteria
* Plans for relocation outside of Philadelphia in the next six months
* Plans for use of weight loss medication or diet pills in the next six months
* Women who wish to start Implanon ® or DMPA prior to discharge but who do not want to be randomized. 5. Issues or concerns in the judgment of the investigator that may compromise the safety of the subject or confound the reliability of compliance and information acquired in this study
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Courtney A Schreiber, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
813000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.